A new study reveals that 12-18 months after hospitalization for COVID-19, patients show significant cognitive decline comparable to 20 years of aging.
The psychedelic DOI, a compound similar to LSD, reduced anxiety in mice by activating specific brain cells called fast-spiking interneurons.
Scientists have discovered that neurons in the human brain recognize the number zero as a numerical value, not just "nothing." ...
Pramipexole, a Parkinson’s disease (PD) drug, impairs decision-making by hyperactivating the brain’s external globus pallidus ...
A new study reveals that infliximab, an anti-inflammatory drug, can improve motivation in patients with depression and high ...
New research reveals that mixed emotions, like feeling both happy and sad, are processed in distinct areas of the brain.
Certain initial symptoms of multiple sclerosis (MS), like blurry vision and sphincter dysfunction, may predict long-term ...
New research reveals that dopamine is not directly responsible for the formation of placebo analgesia, contrary to previous beliefs.
A new study reveals that psilocybin, the active compound in magic mushrooms, may help treat body dysmorphic disorder (BDD) by ...
Scientists have identified the melatonin MT1 receptor as a key regulator of REM sleep, crucial for memory, dreaming, and ...
Male and female mice process threats using different brain circuits, even though their behavioral responses are similar.
Artificial light at night (ALAN), particularly blue light, disrupts fish behavior and affects their offspring.